What's new? Log in Free sign up

Filing search / Cartesian Therapeutics, Inc. / "Talent"

Search information

Cartesian Therapeutics, Inc.

Companies

"Talent"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

22 results

Newest first Best match first

RNAC Cartesian Therapeutics, Inc.

Prospectus with selling stockholder info

both for our business and ultimately our patient populations. We believe in a proactive approach to talent management focusing on retention of key … talent, critical role successor identification, and impactful employment development. Additional priority areas intended to drive engagement include

RNAC Cartesian Therapeutics, Inc.

IPO registration (amended)

populations. We believe in a proactive approach to talent management focusing on retention of key talent, critical role successor identification … , and impactful employment development. Additional priority areas intended to drive engagement include successful recruitment of diverse talent, continual

20 Sep 24

4:17pm

RNAC Cartesian Therapeutics, Inc.

IPO registration (amended)

and ultimately our patient populations. We believe in a proactive approach to talent management focusing on retention of key talent, critical role … of diverse talent, continual promotion of professional development at all levels, introduction, and evolution of business-friendly human resources

9 Sep 24

4:11pm

RNAC Cartesian Therapeutics, Inc.

IPO registration

value creation both for our business and ultimately our patient populations. We believe in a proactive approach to talent management focusing on retention … of key talent, critical role successor identification, and impactful employment development. Additional priority areas intended to drive engagement

2 Aug 24

7:34am

RNAC Cartesian Therapeutics, Inc.

Definitive proxy

and incentivize top talent will be adversely affected if the Plan is not approved. Upon a review of the remaining shares of Common Stock available … key talent for the Company. Additionally, the Board believes an engaged and empowered workforce contributes significantly to the creation

26 Apr 24

9:09am

7 Mar 24

7:08am

0pivuy8442 wrlexv

Definitive proxy

14 Feb 24

4:42pm

Definitive proxy

28 Apr 23

12:00am

cw1x00vpaj1rpo0sq

Preliminary proxy

18 Apr 23

4:34pm

Definitive proxy

3 May 22

8:25am

f1t7m0en g08ede64sv1

Annual report (amended)

28 Apr 22

7:45am

8shms1w7mar 5ex8

Preliminary proxy

Definitive proxy

22 Apr 22

8:00am

q77z2nfyy6dey1g2xcxh

10 Mar 22

8:02am

166t3txtgz0xi97f3

Selecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business Update

x3ih9tcj6924vjfh ng

Definitive proxy

29 Apr 21

8:16am

Definitive proxy

28 Apr 20

8:20am

l6bs44aun10qsq08lv

Definitive proxy

29 Apr 19

8:00am

Definitive proxy

25 Apr 18

5:28pm

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.